Use of ketonal in lumbago
https://doi.org/10.17650/2222-8721-2014-0-1-48-61
Abstract
Lumbago is one of the most common musculoskeletal pain syndromes. The course of lumbago shows a tendency towards frequent relapses and is associated with the significant material costs of medical care. A wide range of analgesics, nonsteroidal anti-inflammatory drugs in particular, whose administration may be linked with an increased risk for adverse visceral reactions, is used to treat patient with lumbago. The risk of their side effects may be reduced by the extensive use of non-drug treatments and the early expansion of a motor regimen in a patient. Therapeutic effectiveness in reducing the likelihood of adverse reactions may be provided by short-term treatment with effective drugs. The advantages of using ketoprofen (ketonal) formulations in patients with lumbago are considered.
About the Authors
P. R. Kamchatnov
N.I. Pirogov Russian National Research Medical University, Moscow
Russian Federation
Russian Federation
Kh. Ya. Umarova
Chechen State University, Grozny
Russian Federation
Russian Federation
References
1. Parsons S., Breen A., Foster N. et al. Prevalence and comparative troublesomeness by age of musculoskeletal pain in different body locations. Fam Pract 2007;24:308–16.
2. Hall H., McIntosh G. Low back pain (acute) Clin Evid 2008;2008:1102–8.
3. Schneider S., Schmitt H., Zoller S., Schiltenwolf M. Workplace stress, lifestyle and social factors as correlates of back pain: a representative study of the German working population. Int Arch Occup Environ Health. 2005;78(4):253–69.
4. Croft P. Is life becoming more of a pain? BMJ 2000;320:1552–3.
5. Mafi J.N., McCarthy E.P., Davis R.B., Landon B.E. Worsening trends in the management and treatment of back pain. JAMA Intern Med 2013;173:1573.
6. Freburger J., Holmes G., Agans R. et al. The rising prevalence of chronic low back pain. Arch Intern Med. 2009;169:251–258.
7. Kim T., Montejano L., Cao Z., Zhao Y. Health care costs in US patients with and without a diagnosis of osteoarthritis. J Pain Res 2012;5:23–30.
8. Есин Р.Г., Есин О.Р., Ахмадеева Г.Д., Салихова Г.В. Боль в спине. Казань, 2010. 272 с.
9. Okumura T., Ohhira M., Kumei S., Nozu T. A higher frequency of lumbar ossification of the posterior longitudinal ligament in elderly in an outpatient clinic in Japan. Int J Gener Med 2013;6:729–32.
10. Никифоров А.С., Авакян Г.Н. Неврологические осложнения остеохондроза позвоночника. М.: Медпрактика, 2011. 256 с.
11. Delitto A., George S., Van Dillen L. et al. Low Back Pain. Clinical Practice Guidelines Linked to the International Classification of Functioning, Disability, and Health from the Orthopaedic Section of the American Physical Therapy Association. J Orthop Sports Phys Ther 2012;42(4):A1–57.
12. Данилов А.Б., Курганова Ю.М. Офисный синдром. РМЖ. Неврология 2012;8;1902–8.
13. Poitras S., Durand M., Côté A., Tousignant M. Guidelines on low back pain disability: interprofessional comparison of use between general practitioners, occupational therapists, and physiotherapists. Spine (Phila Pa 1976) 2012;37(14):1252–9.
14. Montero-Marin J., Garcia-Campayo J., Fajo-Pascual M. et al. Sociodemographic and occupational risk factors associated with the development of different burnout types: the cross–sectional University of Zaragoza study. BMC Psychiatry 2011;11:49–54.
15. Carter Р. 2013 was a horrible year for nursing—nurses are “burnt out”. BMJ 2014;348:g126 doi: 10.1136/bmj.g126.
16. Scott N., Moga C., Harstall C. Managing low back pain in the primary care setting: The know-do gap. Pain Res Manage 2010;15(6):392–400.
17. Williams C., Henschke N., Maher C. et al. Red flags to screen for vertebral fracture in patients presenting with low-back pain. Cochrane Database Syst Rev 2013 Jan 31;1:CD008643.
18. Wertli M., Ruchti K., Steurer J., Held U. Diagnostic indicators of non-cardiovascular chest pain: a systematic review and metaanalysis. BMC Med. 2013 Nov 8;11:239. doi: 10.1186/1741-7015-11-239.
19. McCormack K., Urquhart E. Correlation between nonsteroidal anti-inflammatory drug efficacy in a clinical pain model and the dissociation of their anti-inflammatory and analgesic properties in animal models. Drug Invest 1995;9:88–97.
20. Coxib and traditional NSAID Trialists' (CNT) Collaboration. Vascular and upper gastrointestinal effects of non-steroidal antiinflammatory drugs: meta-analyses of individual participant data from randomised trials. The Lancet, Early Online Publication, 30 May 2013; doi:10.1016/S0140- 6736(13)60900-9.
21. McGettigan P., Henry D. Cardiovascular risk and inhibition of cyclooxygenase. A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase. JAMA 2006;296;13:1–12.
22. Камчатнов П.Р., Чугунов А.В., Трубецкая Е.А. Пациент с болью в спине: возможности терапии. Нервно-мышечные болезни 2013;2:20–7.
23. Riou B., Plaisance P., Lecomte F. et al. Comparison of two doses of ketoprofen to treat pain: a double-blind, randomized, noninferiority trial. Fundam Clin Pharmacol 2013 Jul 24. doi: 10.1111/j.1472-8206.2012.01072.x.
24. Дамулин И.В. Терапевтические возможности при болях в спине вертеброгенного генеза (применение кетопрофена и другие методы лечения). Журн неврол и психиатр 2014;2:81–6.
25. Chou R., Qaseem А., Snow V. et al. Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society. Ann Intern Med. 2007;147(7):478–91.
Review
For citations:
Kamchatnov P.R., Umarova Kh.Ya. Use of ketonal in lumbago. Neuromuscular Diseases. 2014;(1):47-53. (In Russ.) https://doi.org/10.17650/2222-8721-2014-0-1-48-61
Views:
3141
Email this article 